Latest Breaking News On - Jeremym shefner - Page 1 : comparemela.com

NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients

NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Phoenix
Arizona
United-states
Italy
Canada
Israel
Jeremym-shefner
Linkedin

Prilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024

Prilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Netherlands
Israel
Naarden
Noord-holland
Colorado
United-states
Waltham
Massachusetts
Denver
American
Michaelr-hayden
Jina-swarz

Prilenia Therapeutics B.V.: Prilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024

Prilenia Therapeutics B.V.: Prilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Israel
Netherlands
Colorado
Denver
American
Dennis-riedl
Jeremym-shefner
Michaelr-hayden
Jina-swarz
Twitter

Neurosense Therapeutics (NRSN) Announces Peer-Reviewed Publication of PrimeC Phase IIa ALS Study in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Neurosense Therapeutics (NRSN) Announces Peer-Reviewed Publication of PrimeC Phase IIa ALS Study in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Erez-eitan
Avital-pushett
Vivian-drory
Jeremym-shefner
Shiran-zimri
Neurosense-head-of-scientific-program
Barrow-neurological-institute
Clinical-research
Nasdaq
Neurosense-therapeutics-ltd
Sense-therapeutics
Amyotrophic-lateral-sclerosis